Ovarian Cancer Early Detection and Prevention Program
The Northwestern Ovarian Cancer Early Detection and Prevention Program (NOCEDPP), under the direction of Dr. Lee Shulman, is a collaborative effort between Northwestern University and the Robert H. Lurie Comprehensive Cancer Center of Northwestern.
This collaborative effort integrates with the clinical screening of women at high risk of ovarian cancer with the development of new serum and plasma tumor markers for the early detection of ovarian cancer.
What is the purpose of the NOCEDPP?
The purpose of the NOCEDPP is to identify those women who are at increased risk for developing ovarian cancer and to develop new tests, unique to the ovaries, to help detect ovarian cancer at an early, treatable stage.
The (NOCEDPP) provides focused, high quality innovative care and services for asymptomatic women at increased risk of developing ovarian cancer. The hallmark of the program is the coordinated, multidisciplinary services provided during each comprehensive clinic visit.
The NOCEDPP, along with the sections of Gynecologic Oncology, Hematology/Oncology, Surgical Oncology, and the Cancer Genetics Program have joined forces with the Robert H. Lurie Comprehensive Cancer Center. The Cancer Center provides a full range of oncology services and provides access to specialized research, clinical trials and diagnostic services.
Department Chair: Serdar Bulun, MD
Ambulatory Medical Director: Susan Tsai, MD
Division Chief: Lee P. Shulman, MD
Physicians in the Practice
Wednesday: 8 a.m. to 4:30 p.m.
Thursday: 8 a.m. to 4:30 p.m.
675 North St Clair
Chicago, Illinois 60611
Practice Number: 312-926-6606